Ophthalmology · Dallas, TX
NPI
1487910691
Since 2012
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5201 Harry Hines Blvd, Graduate Medical Education
Dallas, TX, 75235
Phone (214) 590-8058
Groups this clinician bills Medicare through
Medicare paid, 2024
$297K
2,541 services
Medicare patients, 2024
1,121
Average age 75
Drug cost, 2024
$436K
3,098 prescriptions
Company payments, 2025
$452
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Severin M Pouly was code 99213 (office e&m - established), 535 times for 416 patients. In total Severin M Pouly billed 2,541 services in 46 codes, and Medicare paid $297K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 535 | 416 | $54.27 | $29K |
| 99214 Office E&M - Established | Office | 371 | 283 | $78.51 | $29K |
| 92014 Ophthalmological E&M | Office | 327 | 322 | $71.62 | $23K |
| 92136 Ultrasound - Nonspecific | Office | 266 | 204 | $29.31 | $7,795 |
| 99204 Office E&M - New | Office | 235 | 235 | $100.88 | $24K |
| 66984 Cataract Surgery | Office | 204 | 127 | $312.39 | $64K |
| 92133 Computerized Ophthalmic Imaging | Office | 80 | 78 | $21.49 | $1,720 |
| 66984 Cataract Surgery | Facility | 68 | 45 | $343.82 | $23K |
| 65400 Eye | Office | 52 | 43 | $464.46 | $24K |
| 92004 Ophthalmological E&M | Office | 49 | 49 | $87.62 | $4,293 |
| 92025 Test - Miscellaneous | Office | 44 | 42 | $20.19 | $888 |
| 92083 Vision, Hearing, and Speech Services | Office | 42 | 37 | $36.87 | $1,549 |
| 65756 Eye | Office | 31 | 31 | $782.81 | $24K |
| 92012 Ophthalmological E&M | Office | 29 | 29 | $54.83 | $1,590 |
| 92134 Computerized Ophthalmic Imaging | Office | 28 | 26 | $27.93 | $782 |
By year: 2022 $380K for 3,178 services; 2023 $317K for 2,707 services; 2024 $297K for 2,541 services.
Medicare prescription drug claims, 2024
In 2024, the drug Severin M Pouly prescribed most often to Medicare patients was Prednisolone Acetate, with 578 prescriptions and refills. In total Severin M Pouly wrote 3,098 Medicare prescriptions that cost $436K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 578 | 940 | 293 | $25K |
| Fluorometholone Generic | 535 | 973 | 220 | $41K |
| Valacyclovir Valacyclovir Hcl | 264 | 363 | 64 | $8,922 |
| Moxifloxacin Moxifloxacin Hcl | 227 | 232 | 118 | $6,829 |
| Timolol Maleate Generic | 178 | 287 | 51 | $2,661 |
| Restasis Cyclosporine | 176 | 204 | 47 | $122K |
| Latanoprost Generic | 152 | 253 | 35 | $1,226 |
| Ketorolac Tromethamine Generic | 137 | 172 | 105 | $2,633 |
| Ofloxacin Generic | 122 | 126 | 108 | $1,494 |
| Erythromycin Erythromycin Base | 109 | 109 | 45 | $1,043 |
| Brimonidine Tartrate Generic | 108 | 179 | 35 | $1,123 |
| Cyclosporine Generic | 58 | 72 | 19 | $25K |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 51 | 66 | 43 | $335 |
| Doxycycline Hyclate Generic | 50 | 56 | 27 | $1,306 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 49 | 106 | 14 | $739 |
Brand drugs: 1,261 claims; generic drugs: 1,837 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Severin M Pouly $452 ($452 in general payments such as food, travel and fees) from 7 companies. The largest payer was Glaukos Corporation with $142.
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation GKOS | 4 | $142 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $118 |
| Abbvie Inc. ABBV | 3 | $75.77 |
| Alcon Vision LLC ALC | 2 | $43.25 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $27.61 |
| Dompe US, Inc. | 1 | $26.79 |
| Mallinckrodt Hospital Products Inc. | 1 | $19.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.